Investigation of Sample Rejection Reasons According to Pre-Preanalytical Errors, Which are Quality Indicators in the Central Laboratory of a University Hospital
Öz
Background: The preanalytical phase includes all steps from patient preparation to sample collection, labeling, transportation, and acceptance for analysis. A significant proportion of laboratory errors occur during this phase and may adversely affect patient safety. This study aimed to determine the causes of sample rejection due to preanalytical errors in the central laboratory of a university hospital and to evaluate rejection rates.
Materials and Methods: This retrospective study analyzed data from the laboratory information system (LIS) for samples accepted between January 1 and June 30, 2025 in the Central Laboratory of University Faculty of Medicine. Samples requested for biochemistry, hemogram, hormone, specific hormone, coagulation, sedimentation, cardiac, and HbA1c tests were included. Sample rejection reasons were classified according to national laboratory quality indicators and rejection rates were calculated as percentages.
Results: During the six-month period, 848,343 samples were accepted and 18,058 samples were rejected, resulting in an overall rejection rate of 2.13%. The most common reasons for rejection were insufficient sample volume (54.75%), clotted samples (38.91%), and incorrect tube type (2.94%). The highest proportions of rejected samples were observed in the sedimentation (32.83%), hemogram (32.59%), and coagulation (22.57%) laboratory units. Rejection rates differed significantly among laboratory units (p<0.001).
Conclusions: Preanalytical errors remain one of the main causes of sample rejection in clinical laboratories. The high frequency of insufficient and clotted samples indicates the need for improved phlebotomy practices and enhanced training programs for healthcare personnel. Continuous monitoring of the preanalytical process and regular staff training may contribute to improving laboratory quality indicators and ensuring patient safety.
Anahtar Kelimeler
- Preanalytical Errors
- Sample Rejection
- Laboratory Quality Indicators
- Preanalytical Phase
- Laboratory Information System
Destekleyen Kurum
Etik Beyan
Kaynakça
- Lippi G. Unveiling the hidden clinical and economic impact of preanalytical errors. Turkish Journal of Biochemistry. 2025;50(3):331-8.
- Plebani M, Scott S, Simundic AM, Cornes M, Padoan A, Cadamuro J, et al. New insights in preanalytical quality. Clin Chem Lab Med. 2025;63(9):1682-92.
- Nordin N, Ab Rahim SN, Wan Omar WFA, Zulkarnain S, Sinha S, Kumar S, Haque M. Preanalytical Errors in Clinical Laboratory Testing at a Glance: Source and Control Measures. Cureus. 2024;16(3):e57243.
- Simundic A-M, Lippi G. Preanalytical phase – a continuous challenge for laboratory professionals. Biochemia Medica. 2012;22(2):145-9.
- Lippi G, Simundic AM, European Federation for Clinical C, Laboratory Medicine Working Group for Preanalytical P. The EFLM strategy for harmonization of the preanalytical phase. Clin Chem Lab Med. 2018;56(10):1660-6.
- Plebani M. Quality indicators to detect pre-analytical errors in laboratory testing. Clin Biochem Rev. 2012;33(3):85-8.
- Plebani M, Sciacovelli L, Aita A, Chiozza ML. Harmonization of pre-analytical quality indicators. Biochem Med (Zagreb). 2014;24(1):105-13.
- ISO 15189:2022 Medical laboratories — Requirements for quality and competence. Geneva: International Organization for Standardization; 2022.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Tıbbi Biyokimya ve Metabolomik (Diğer)
Bölüm
Araştırma Makalesi
Yazarlar
Aysun Ekinci
*
0000-0002-0547-4139
Türkiye
Yayımlanma Tarihi
26 Haziran 2026
Gönderilme Tarihi
25 Mart 2026
Kabul Tarihi
20 Mayıs 2026
Yayımlandığı Sayı
Yıl 2026 Cilt: 23 Sayı: 2